Nephros, Inc

(NASDAQ:NEPH)

Latest On Nephros, Inc (NEPH):

Date/Time Type Description Signal Details
2023-05-13 02:29 ESTNewsNephros, Inc. (NEPH) Q1 2023 Earnings Call TranscriptN/A
2023-05-10 18:37 ESTNewsNephros GAAP EPS of -$0.03 misses by $0.01, revenue of $3.7M beats by $0.02MN/A
2023-04-04 17:59 ESTNewsNephros gives early look at Q1 numbersN/A
2023-03-09 04:29 ESTNewsNephros, Inc. (NEPH) Q4 2022 Earnings Call TranscriptN/A
2023-03-02 19:40 ESTNewsNephros and Donastar enter new strategic partnershipN/A
2023-01-11 12:41 ESTNewsNephros guides Q4 and FY22 revenue slightly below estimatesN/A
2022-11-06 11:52 ESTNewsNephros, Inc. (NEPH) Q3 2022 Earnings Call TranscriptN/A
2022-11-02 20:52 ESTNewsNephros GAAP EPS of -$0.31 misses by $0.20, revenue of $2.41M misses by $0.11MN/A
2022-09-28 22:09 ESTNewsNephros partners with Donastar and Tractor Beverage to supply and service nationwide fast-casual restaurant operationN/A
2022-08-11 13:00 ESTNewsNephros, Inc.'s (NEPH) CEO Andy Astor on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-10 20:51 ESTNewsNephros GAAP EPS of -$0.12 beats by $0.02, revenue of $2.8M misses by $0.08MN/A
2022-05-17 13:27 ESTNewsNephros' HDF assist module gets FDA nod for hemodiafiltration therapy for kidney disease patientsN/A
2022-05-08 01:59 ESTNewsNephros, Inc. (NEPH) CEO Andy Astor on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-05 06:42 ESTNewsNephros GAAP EPS of -$0.20 misses by $0.09, revenue of $2.18M misses by $0.92MN/A
2022-02-23 22:40 ESTNewsNephros reports Q4 resultsN/A
2022-02-23 22:40 ESTNewsNephros, Inc. (NEPH) CEO Andy Astor on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-11 15:41 ESTNewsNephros anticipates a record 21% growth in FY21 revenue, updates FY22 guidanceN/A
2021-11-07 19:14 ESTNewsNephros, Inc. (NEPH) CEO Andy Astor on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-05 10:26 ESTNewsNephros EPS misses by $0.01, revenue in-lineN/A
2021-10-12 10:08 ESTNewsWarning: NEPH is at high risk of performing badlyN/A
2021-10-11 15:04 ESTNewsNEPH is at high risk of performing badlyN/A
2021-10-08 12:23 ESTNewsNephros sees 24% growth in Q3 prelim net revenueN/A
2021-10-01 18:22 ESTNewsWarning: NEPH has been downgraded to Very BearishN/A
2021-08-07 22:08 ESTNewsNephros, Inc. (NEPH) CEO Andrew Astor on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-06 07:28 ESTNewsNephros EPS misses by $0.01, beats on revenueN/A
2021-07-21 16:27 ESTNewsNephros sees 40% growth in Q2 prelim revenueN/A
2021-07-21 16:26 ESTNewsNephros acquires GenArraytion; terms not disclosedN/A
2021-05-07 12:25 ESTNewsNephros EPS beats by $0.05, beats on revenueN/A
2021-04-05 12:22 ESTNewsNephros preannounces Q1 resultsN/A
2021-03-03 00:36 ESTFinancialsCompany financials have been released.Neutral
2021-03-02 08:14 ESTEarnings EstimateAn EPS average of -$0.04 is estimated for the 2022 year.Buy
2021-03-02 08:14 ESTEarnings EstimateAn EPS average of -$0.10 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-01 21:17 ESTNewsNephros beats on revenueN/A
2021-03-01 21:17 ESTNewsNephros, Inc. (NEPH) CEO Andy Astor on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-10 08:07 ESTAnalyst RatingThe Analyst Target Price has increased from $12.81 to $13.83.Buy
2021-01-27 04:06 ESTAnalyst RatingThe Analyst Target Price has decreased from $12.92 to $12.81.Neutral
2021-01-27 03:07 ESTNewsNephros is up as B Riley inititates coverage with a BuyN/A
2021-01-12 11:32 ESTNewsNephros sees Q4 revenue in-line with estimates,N/A
2021-01-06 16:17 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 20:57 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 04:50 ESTAnalyst RatingThe Analyst Target Price has decreased from $13.33 to $12.92.Neutral
2020-11-10 04:32 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:35 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 13:02 ESTNewsNephros, Inc.'s (NEPH) CEO Andy Astor on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-06 14:25 ESTNewsNephros EPS beats by $0.02, misses on revenueN/A
2020-11-06 08:27 ESTEarnings EstimateAn EPS average of -$0.12 is estimated for the quarter ending on March 31, 2021.N/A
2020-10-16 16:42 ESTInsider TradeCAPITAL LP WEXFORD has indirectly acquired of 166,667 shares.Buy
2020-10-06 18:01 ESTNewsNephros Q3 prelim revenues grow 34% Q/QN/A
2020-09-26 13:31 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 05:37 ESTFinancialsCompany financials have been released.Neutral

About Nephros, Inc (NEPH):

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company operates through three segments: Water Filtration, Pathogen Detection, and Renal Products. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company develops and sells water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. Nephros, Inc. was incorporated in 1997 and is headquartered in South Orange, New Jersey.

NEPH Quotes by TradingView

See Advanced Chart

General

  • Name Nephros, Inc
  • Symbol NEPH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • Full Time Employees 27
  • Last Split Factor1:9
  • Last Split Date2019-07-10
  • Fiscal Year EndDecember
  • IPO Date2004-09-21
  • Gic SectorConsumer Discretionary
  • Gic GroupConsumer Durables & Apparel
  • Gic IndustryHousehold Durables
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://www.nephros.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 8.08
  • Price/Book (Most Recent Quarter) 6.03
  • Enterprise Value Revenue 8.11
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.34
  • Next Year EPS Estimate -$0.10
  • Next Quarter EPS Estimate -$0.13
  • Profit Margin -56%
  • Operating Margin -53%
  • Return on Assets -19%
  • Return on Equity -39%
  • Revenue 8.56 million
  • Earnings Per Share -$0.52
  • Revenue Per Share $0.94
  • Gross Profit 4.91 million
  • Quarterly Earnings Growth -26.2%
View More

Highlights

  • Market Capitalization 74.37 million
  • EBITDA -3209000
  • Analyst Target Price $13.83
  • Book Value Per Share $1.27
View More

Share Statistics

  • Shares Outstanding 9.91 million
  • Shares Float 3.97 million
  • % Held by Insiders 1197%
  • % Held by Institutions 53.08%
  • Shares Short 9862
  • Shares Short Prior Month 12533
  • Short Ratio 0.46
View More

Technicals

  • Beta 1.24
  • 52 Week High $10
  • 52 Week Low $5.08
  • 50 Day Moving Average 8.02
  • 200 Day Moving Average 7.21
View More

Dividends

  • Dividend Date 2019-07-10
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Nephros, Inc (NEPH) Dividend Calendar:

NEPH's last dividend payment was made to shareholders on July 10, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Nephros, Inc (NEPH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.08-$0.1230.43%
2020-09-302020-11-05$2.12 million-$0.14-$0.14-1.68%
2020-06-302020-08-05$N/A-$0.19-$0.15-26.67%
2020-03-312020-05-06$2.53 million-$0.13-$0.09-39.34%
2019-12-312020-02-27$3.16 million-$0.03-$0.1174.4%
2019-09-302019-11-06$3.1 million-$0.10-$0.10-0.41%
2019-06-302019-08-07$2.31 million-$0.14-$0.1822.22%
2019-03-312019-05-08$1.77 million-$0.18-$0.09-100%
2018-12-312019-03-12$1.61 million-$0.10
2018-09-302018-11-08$1.72 million-$0.08
2018-06-302018-08-08$1.37 million-$0.10
2018-03-312018-05-09$985000-$0.23
2017-12-312018-02-26$1.3 million$0.21
2017-09-302017-11-09$916000-$0.11
2017-06-302017-08-08$859000-$0.13
2017-03-312017-05-09$734000-$0.12
2016-12-312017-03-20$745000-$0.12
2016-09-302016-11-10$476000-$0.13
2016-06-302016-08-15$509000-$0.15
2016-03-312016-05-12$590000-$0.16
2015-12-312016-03-30$511000-$0.19
2015-09-302015-11-11$321000-$0.16
2015-06-302015-08-10$568000-$0.18
2015-03-312015-05-12$544000-$0.19
2014-12-312015-03-19$342000-$1.56
2014-09-302014-11-14$491000-$0.25
2014-06-302014-08-12$442000-$0.23
2014-03-312014-05-13$473000-$0.36
2013-12-312014-03-28$226000-$0.63
2013-09-302013-11-15$418000-$0.31
2013-06-302013-08-13$575000-$0.41
2013-03-312013-05-09$521000-$0.93
2012-12-312013-02-27$368000-$0.88
2012-09-302012-11-16$604000-$0.66
2012-06-302012-08-14$302000-$0.62
2012-03-312012-05-15$533000-$0.47
2011-12-312012-02-29$489000-$0.66
2011-09-302011-11-14$407000-$0.37
2011-06-302011-08-16$637000-$0.54
2011-03-312011-05-12$681000-$1.60
2010-12-312011-03-02$517000-$2.97
2010-09-302010-11-12$622000-$1.61
2010-06-302010-08-17$810000-$1.57
2010-03-312010-05-13$989000-$2.28
2009-12-312010-03-03$792000-$2.19
2009-09-302009-11-13$711000-$1.76
2009-06-302009-08-17$527000-$1.94
2009-03-312009-05-14$631000-$3.47
2008-09-302008-11-17$393000-$6.35
2008-06-302008-08-14$253000-$11.53
2008-03-312008-05-15$387000-$7.73
2007-09-302007-11-14$111000-$21.36
2007-06-302007-08-14$348000-$23.82
2007-03-312007-04-10$296000-$27.00-$34.2021.05%
2006-12-312007-02-28$152000-$32.95
2006-09-302006-11-15$165000-$27.00-$32.4016.67%
2006-06-302006-08-22$302000-$32.40-$28.80-12.5%
2006-03-312006-05-22$174000-$29.93
2005-09-302005-11-14$225000-$25.56
2005-06-302005-08-15$226000-$29.73
2005-03-312005-05-15$1.9 million-$5.82
2004-09-302004-11-14$46000-$699.80

Nephros, Inc (NEPH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Nephros, Inc (NEPH) Chart:

Nephros, Inc (NEPH) News:

Below you will find a list of latest news for Nephros, Inc (NEPH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Nephros, Inc (NEPH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest NEPH Trades:

Date Shares Price
Jun 13, 2022 7:41 PM EST6$1.78

Nephros, Inc (NEPH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419020000192/0000914190-20-000192-index.htm
2019-11-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419019000424/0000914190-19-000424-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419019000501/0000914190-19-000501-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419019000502/0000914190-19-000502-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419019000505/0000914190-19-000505-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419019000506/0000914190-19-000506-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419019000507/0000914190-19-000507-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419019000508/0000914190-19-000508-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419019000509/0000914190-19-000509-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419019000510/0000914190-19-000510-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419020000041/0000914190-20-000041-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419020000042/0000914190-20-000042-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419020000105/0000914190-20-000105-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419020000107/0000914190-20-000107-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419020000112/0000914190-20-000112-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419020000113/0000914190-20-000113-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419020000169/0000914190-20-000169-index.htm
2020-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419020000192/0000914190-20-000192-index.htm
2020-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419020000331/0000914190-20-000331-index.htm
2020-08-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000091419020000355/0000914190-20-000355-index.htm
2020-10-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1196298/000091957420006454/0000919574-20-006454-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000104846220000017/0001048462-20-000017-index.htm
2020-10-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1196298/000104846220000019/0001048462-20-000019-index.htm
2020-10-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1196298/000114036120023502/0001140361-20-023502-index.htm
2020-09-04D/ANotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1196298/000143774920019341/0001437749-20-019341-index.htm
2019-11-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1196298/000149315219018516/0001493152-19-018516-index.htm
2019-11-27S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1196298/000149315219018518/0001493152-19-018518-index.htm
2019-12-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1196298/000149315219018714/0001493152-19-018714-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315219019699/0001493152-19-019699-index.htm
2020-01-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220000178/0001493152-20-000178-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220000395/0001493152-20-000395-index.htm
2020-01-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220001128/0001493152-20-001128-index.htm
2020-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220001424/0001493152-20-001424-index.htm
2020-01-31424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1196298/000149315220001460/0001493152-20-001460-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1196298/000149315220003069/0001493152-20-003069-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220003073/0001493152-20-003073-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220005652/0001493152-20-005652-index.htm
2020-04-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1196298/000149315220006059/0001493152-20-006059-index.htm
2020-04-08DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1196298/000149315220006060/0001493152-20-006060-index.htm
2020-04-08SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1196298/000149315220006063/0001493152-20-006063-index.htm
2020-04-10424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1196298/000149315220006160/0001493152-20-006160-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1196298/000149315220007823/0001493152-20-007823-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220007908/0001493152-20-007908-index.htm
2020-05-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1196298/000149315220008238/0001493152-20-008238-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220008239/0001493152-20-008239-index.htm
2020-05-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1196298/000149315220009628/0001493152-20-009628-index.htm
2020-05-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220009705/0001493152-20-009705-index.htm
2020-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220012795/0001493152-20-012795-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1196298/000149315220014717/0001493152-20-014717-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220014725/0001493152-20-014725-index.htm
2020-08-058-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220014726/0001493152-20-014726-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220015844/0001493152-20-015844-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220018976/0001493152-20-018976-index.htm
2020-10-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220019345/0001493152-20-019345-index.htm
2020-10-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220019530/0001493152-20-019530-index.htm
2020-10-16424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1196298/000149315220019541/0001493152-20-019541-index.htm
2020-10-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220019667/0001493152-20-019667-index.htm
2020-10-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220020123/0001493152-20-020123-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1196298/000149315220020593/0001493152-20-020593-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1196298/000149315220020597/0001493152-20-020597-index.htm
2019-12-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1196298/999999999519002752/9999999995-19-002752-index.htm

Nephros, Inc (NEPH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nephros, Inc (NEPH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1197%
Institutional Ownership: 5308%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-11-25Oliver J. SpandowDirectorBuy1,000.008.178,170.0010,786.00https://www.sec.gov/Archives/edgar/data/1196298/000091419019000424/0000914190-19-000424-index.htm
2019-12-16Daron EvansPresident and CEOBuy9,282.00129,215.00https://www.sec.gov/Archives/edgar/data/1196298/000091419019000509/0000914190-19-000509-index.htm
2020-03-05Daron EvansPresident and CEOBuy2,500.008.4421,109.00131,715.00https://www.sec.gov/Archives/edgar/data/1196298/000091419020000107/0000914190-20-000107-index.htm
2020-03-12Daron EvansPresident and CEOBuy2,500.006.6516,625.00134,215.00https://www.sec.gov/Archives/edgar/data/1196298/000091419020000113/0000914190-20-000113-index.htm
2019-12-16Oliver J. SpandowDirectorBuy3,448.0014,234.00https://www.sec.gov/Archives/edgar/data/1196298/000091419019000507/0000914190-19-000507-index.htm
2019-12-16Tom GwydirDirectorBuy2,365.002,365.00https://www.sec.gov/Archives/edgar/data/1196298/000091419019000506/0000914190-19-000506-index.htm
2019-12-16ARTHUR H AMRONDirectorBuy3,448.003,448.00https://www.sec.gov/Archives/edgar/data/1196298/000091419019000502/0000914190-19-000502-index.htm
2019-12-16Paul A MieyalDirectorBuy3,448.003,448.00https://www.sec.gov/Archives/edgar/data/1196298/000091419019000501/0000914190-19-000501-index.htm
2019-12-16Alisa LaskDirectorBuy3,227.003,477.00https://www.sec.gov/Archives/edgar/data/1196298/000091419019000508/0000914190-19-000508-index.htm
2020-10-15CAPITAL LP WEXFORDDirectorBuy166,667.006.001,000,002.003,605,471.00https://www.sec.gov/Archives/edgar/data/1196298/000104846220000017/0001048462-20-000017-index.htm
2019-12-16MALCOLM C PERSENDirectorBuy5,437.0042,853.00https://www.sec.gov/Archives/edgar/data/1196298/000091419019000505/0000914190-19-000505-index.htm
2019-12-16Andrew AstorCFO/COOBuy6,848.0068,308.00https://www.sec.gov/Archives/edgar/data/1196298/000091419019000510/0000914190-19-000510-index.htm
2020-03-05Andrew AstorCFO/COOBuy700.008.465,919.6969,008.00https://www.sec.gov/Archives/edgar/data/1196298/000091419020000105/0000914190-20-000105-index.htm
2020-03-12Andrew AstorCFO/COOBuy1,000.006.706,700.0070,008.00https://www.sec.gov/Archives/edgar/data/1196298/000091419020000112/0000914190-20-000112-index.htm
2020-05-28Andrew AstorCFO/COOBuy1,000.006.966,960.0071,008.00https://www.sec.gov/Archives/edgar/data/1196298/000091419020000192/0000914190-20-000192-index.htm
2020-08-19Andrew AstorCOO/CFOBuy950.007.407,030.0071,958.00https://www.sec.gov/Archives/edgar/data/1196298/000091419020000331/0000914190-20-000331-index.htm